Warning: mysql_real_escape_string(): Access denied for user ''@'localhost' (using password: NO) in /home/eureporterchina/public_html/mix/wp-content/plugins/easy-contact-forms/easy-contact-forms-database.php on line 152

Warning: mysql_real_escape_string(): A link to the server could not be established in /home/eureporterchina/public_html/mix/wp-content/plugins/easy-contact-forms/easy-contact-forms-database.php on line 152

Warning: mysql_real_escape_string(): Access denied for user ''@'localhost' (using password: NO) in /home/eureporterchina/public_html/mix/wp-content/plugins/easy-contact-forms/easy-contact-forms-database.php on line 191

Warning: mysql_real_escape_string(): A link to the server could not be established in /home/eureporterchina/public_html/mix/wp-content/plugins/easy-contact-forms/easy-contact-forms-database.php on line 191
Von der Leyen says two vaccines could receive market authorisation before the end of the year : EU Reporter China

Von der Leyen says two vaccines could receive market authorisation before the end of the year

| November 19, 2020 | 0 Comments

By EU Reporter Correspondent

EU leaders met via video conference this evening (19 December) to discuss the EU response to the COVID-19 pandemic. President of the European Commission Ursula von der Leyen said that the European Medicine Agency (EMA) could authorize two vaccines as early as the second half of December 2020

Von der Leyen welcomed that all member states had signed up to buy the same vaccines selected by the Commission so far. The portfolio of five vaccines and soon six. Von der Leyen said that the different vaccines might work better with different sections of the population, therefor this was a good approach.Â

The Commission president underlined that all vaccines would be properly assessed by the EMA. EMA is working closely with similar agencies, in particular, the United States, Food and Drug Agency. If all goes well the Pfizer/BioNTech and Moderna vaccines could receive their final authorisation for use before the end of the year.Â

Leaders discussed how to speed up the preparations of national vaccination plans to ensure vaccines are available and affordable to all EU citizens.

Both President von der Leyen and President of the European Council Charles Michel recognised that communications surrounding deployment would need to be strengthened, as the number of people who are distrustful of vaccines is growing.

EU leaders also discussed the use of antigen tests, their approval and their mutual recognition. Leaders discussed how to develop a common EU-approach for the use of rapid antigen tests. The tests are complementary to PCR tests which are much more expensive and slower. National testing strategies were discussed and leaders agreed to work towards mutual recognition of tests and their results, as well as common criteria for assessing tests.

The leaders also discussed the lifting of travel restrictions. Charles Michel said: “We need to learn past lessons and be cautious when we lift restrictions. It should be gradual and regressive. We all want to celebrate the end of year holidays but safely. Let’s ring in the New Year safely.â€�

Source:: EU Reporter Feed

Comments

comments

Category: Energy, Uncategorized

About the Author ()

Leave a Reply

Your email address will not be published. Required fields are marked *